Blj Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 16 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -3.45%
- Profit Growth -8.98%
- Ebitda -26.31%
- Net Worth 5.76%
- Total Assets -2.13%
About Blj Pharmaceuticals
Blj Pharmaceuticals Private Limited (BPPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 August 2008 and has a history of 16 years and five months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rupali Jain and Pranjal Jain serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232DL2008PTC182488
-
Company No.
182488
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Aug 2008
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Blj Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rupali Jain
|
Director | 26-Dec-2018 | Current |
|
Pranjal Jain
|
Director | 20-Feb-2021 | Current |
Financial Performance of Blj Pharmaceuticals.
Blj Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.45% decrease. The company also saw a slight decrease in profitability, with a 8.98% decrease in profit. The company's net worth moved up by a moderate rise of 5.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Blj Pharmaceuticals?
In 2023, Blj Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Reso Technologies Private LimitedPranjal Jain is a mutual person
-
Gautam Budh Management Institute Private LimitedRupali Jain is a mutual person
-
Gautam Budh Garments Private Limited
Rupali Jain is a mutual person
-
Green Flavour Private Limited
Rupali Jain is a mutual person
-
S A P Infrastructure Private Limited
Rupali Jain is a mutual person
-
Anekant Textiles Park Private Limited
Rupali Jain is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Blj Pharmaceuticals?
Unlock and access historical data on people associated with Blj Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Blj Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Blj Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
